Skip to main content

AS/Spondyloarthritis

Update on Axial SpA at #EULAR2022

This year at EULAR 2022, there were important and interesting topics in Axial Spondy

Dr. John Cush RheumNow

1 month ago
Update on Axial SpA at #EULAR2022 This year at EULAR 2022, there were important and interesting topics in Axial Spondyloarthritis (AxSpA). Dr Antoni Chan shares his picks of abstracts from the conference.https://t.co/AhUC7ORrZi https://t.co/1olLoNS5Ey
Spondyloarthritis and COVID-19

With the availability of vaccines and new therapeutics, many of our patients are fully v

Dr. John Cush RheumNow

1 month ago
Spondyloarthritis and COVID-19 With the availability of vaccines and new therapeutics, many of our patients are fully vaccinated. We know this can limit their chances of severe COVID all while allowing their rheumatic disease to be treated. #EULAR2022 https://t.co/PmQNKYg1Ao https://t.co/N4DJVYJqrL
Axial Spondyloarthritis
This year at EULAR 2022, there were important and interesting topics in Axial Spondyloarthritis (AxSpA). These are my picks of abstracts from the conference. Non-steroidal anti-inflammatory drugs (…
RT @doctorRBC: New biomarker for atherosclerosis, cardiovascular risk and disease activity in axSpA?
Low Irisin associat

Robert B Chao, MD doctorRBC

1 month ago
New biomarker for atherosclerosis, cardiovascular risk and disease activity in axSpA? Low Irisin associated with subclinical atherosclerosis, high CV risk and more severe disease activity in axSpA @RheumNow #EULAR2022 ABST#POS0327
RT @drdavidliew: Sex differences in axSpA: we’re continuing to better understand the differences in imaging findings.

David Liew drdavidliew

1 month ago
Sex differences in axSpA: we’re continuing to better understand the differences in imaging findings. Existing MRI scoring may underserve axSpA in women. Added to therapy differences, a lot to readdress for our female axSpA patients. from roundup #EULAR2022 @RheumNow https://t.co/8wCKx9AFcM
RT @doctorRBC: Gut microbiome of AS patients different from healthy controls. Different bacteria communities may be asso

Robert B Chao, MD doctorRBC

1 month ago
Gut microbiome of AS patients different from healthy controls. Different bacteria communities may be associated with disease activity. So much more to digest.... @RheumNow #EULAR2022 ABST#POS0330 https://t.co/EAvHngd6SD
RT @doctorRBC: Tofacitinib had faster and larger impact on improvement of fatigue compared to placebo in treatment of an

Robert B Chao, MD doctorRBC

1 month ago
Tofacitinib had faster and larger impact on improvement of fatigue compared to placebo in treatment of ankylosing spondylitis pts. Note 100% fatigue resolution roughly same vs. placebo @RheumNow #EULAR2022 ABST#POS0305 https://t.co/Doep91QIRa
RT @doctorRBC: Upadacitinib effective in treatment of ankylosing spondylitis pts refractory to biologic tx - phase 3 tri

Robert B Chao, MD doctorRBC

1 month ago
Upadacitinib effective in treatment of ankylosing spondylitis pts refractory to biologic tx - phase 3 trial Primary endpoint (ASAS40) and secondary endpoints met No malignancy, MACE, VTE, death @RheumNow #EULAR2022 ABST#POS0306 https://t.co/UL4hUJ0rQV
×